The trajectory of Sildenafil presents a challenging picture for shareholders. While the initial introduction generated substantial profits, the end of its exclusive rights opened the door to off-brand alternatives, https://bookmarkbells.com/story21714634/viagra-and-pharma-a-precarious-investment